The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
Agree with you Chaz. You don't say "the recent well-supported ÂŁ2mln fundraise... will be used for completing its development" 3 weeks before Bleepa is shown to the public. It should not be completing development at this point. It should have been written with no further changes allowed and that version thoroughly tested by now. FFS they should not be talking about "completing its development". They should be practicing their speech writing and sales pitch from this point onwards.
https://twitter.com/AndrewScottTV/status/1161976815742836737
Simon Eccles - Chief Clinical Information Officer for Health and Care. Deputy CEO NHSX.
https://twitter.com/BleepaMe/status/1160458284496760832
WhatsApp Doc? New device answers SOS.
https://www.businessweekly.co.uk/news/biomedtech/whatsapp-doc-new-device-answers-sos
Sonie, I do believe you are polishing up your ballpark figures. Didn't you have 10-15p yesterday? Stop worrying about it. Nothing we say or do will have a lasting effect here. Que sera sera.
https://www.youtube.com/watch?v=xZbKHDPPrrc
Balaji at the AI in Radiology meeting he attended. Starts talk at 03:30 approx. Note the Siemens Healthineers logo in the background early on.
https://www.expresshealthcare.in/healthcare-videos/radiology-videos/panel-discussion-on-artificial-intelligence-in-radiology-where-are-we-today-rad2024/413031/
All guessing Bob. I don't have time to do more than guess. I'd go for there being around 2 million left on the MM's books. Sounds a lot? Not really. Last time I checked there were 4-5 companies making a book in Feedback. Evenly spread, it would mean around 500k shares for each MM. That can easily go.
Do I think there are more shares to be sold? No. You know who I suspect is behind this and he likes to sell in round numbers until his last trade. Today's trade ended in '548' from memory. I reckon he's done for the time being.
No idea if these shares were 'borrowed' or not but if they were it would explain the lack of holdings RNS whilst accumulation was underway. Personally, I hope they were borrowed because there's a strong likelihood of him making a loss when he is required to hand them back.
Can't think of more to say right now. Hope it helps.
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: a multicentre retrospective study
https://www.sciencedirect.com/science/article/abs/pii/S0720048X1930261X
Method
One hundred and four patients were enrolled from 3 different centers. CT was performed using similar parameters among different scanners. CTHA was performed with the proprietary software TexRAD, which extracts histogram features at different spatial scale (spatial scale filters, SSF) producing 30 CTHA features per patients. Cross-validated Least Absolute Shrinkage and Selection Operator LASSO was used to select those features which were related to overall and progression-free survival (OS and PFS, respectively). High- and low-risk subgroups were identified using the best cutoff.
Stumbled upon this tonight. Believe the following is a new addition.
Https://www.sinc.co.uk/member-directory/texrad
For Imaging and PACS OEMs:
* additional and unique product for all existing imaging clients (differentiator)
* novel technology with no current competition (patent applied for)
* software – no hardware modifications required
* offered as an add-on or software bundle